RHBC
ZYNE

R.H. Bluestein & Co’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

R.H. Bluestein & Co’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-25,200
Closed -$428K – 344
2017
Q2 		$428K Sell
25,200
-21,650
-46% -$368K 0.02% 155
2017
Q1 		$942K Buy
+46,850
New +$942K 0.06% 82